{"id":131,"count":82,"description":"<h2><strong>We Made it Easy for You!<\/strong><\/h2>\r\nClear, fair, and competitive Thought Leader compensation is a critical factor for the success of your organization. Thought leaders and KOLs play an important role and staying on top of fair market value (FMV) compensation rates will help you attract and keep the best KOLs. Arx Research Thought Leader Compensation Data reports and services help legal, compliance and medical affair executives refine and support the development of Thought Leaders and HCPs fee schedules that are aligned with market conditions.\u00a0Our team of experts regularly sifts through thousands of data points using our exclusive methodology to identify and segment thought leaders, physicians, and KOLs, and then determine their fair market value.\r\n\r\n<strong>Fair-Market Value Compensation rates are available for up to 15 specialties, 4 levels of KOL influence, for half-day flat, and hourly compensation rates for 80 countries. Using our carefully constructed compensation reports allows you to use KOL-FMVs and physician fair market values to confidently set payment rates for external experts working with your organization<\/strong>.\r\n\r\nQuickly gain access to your FMV rates by selecting the report(s) below or contact us to request a brochure, learn about additional rates by therapeutic areas, countries, or for specific activities, and for customization of data. Email <a href=\"mailto:info@arxresearch.com\">info@arxresearch.com <\/a>or call +1 617-233-6736","link":"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/","name":"KOL FMV Rates","slug":"thought-leader-compensation","taxonomy":"product_cat","parent":0,"meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>KOL FMV - Thought Leader Compensation Rates for Pharma KOLs<\/title>\n<meta name=\"description\" content=\"Reports on Fair-Market Value Thought Leader compensation rates made by pharma to HCPs\/KOLs for various activities, specialties, KOL levels and countries.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"KOL FMV - Thought Leader Compensation Rates for Pharma KOLs\" \/>\n<meta property=\"og:description\" content=\"Reports on Fair-Market Value Thought Leader compensation rates made by pharma to HCPs\/KOLs for various activities, specialties, KOL levels and countries.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/\" \/>\n<meta property=\"og:site_name\" content=\"Arx Research\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"CollectionPage\",\"@id\":\"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/\",\"url\":\"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/\",\"name\":\"KOL FMV - Thought Leader Compensation Rates for Pharma KOLs\",\"isPartOf\":{\"@id\":\"https:\/\/www.arxresearch.com\/#website\"},\"description\":\"Reports on Fair-Market Value Thought Leader compensation rates made by pharma to HCPs\/KOLs for various activities, specialties, KOL levels and countries.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/#breadcrumb\"},\"inLanguage\":\"en-US\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arxresearch.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KOL FMV Rates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arxresearch.com\/#website\",\"url\":\"https:\/\/www.arxresearch.com\/\",\"name\":\"Arx Research\",\"description\":\"Medical Affairs Benchmarking\",\"publisher\":{\"@id\":\"https:\/\/www.arxresearch.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arxresearch.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arxresearch.com\/#organization\",\"name\":\"Arx Research\",\"url\":\"https:\/\/www.arxresearch.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png\",\"contentUrl\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png\",\"width\":217,\"height\":100,\"caption\":\"Arx Research\"},\"image\":{\"@id\":\"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/arx-research\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KOL FMV - Thought Leader Compensation Rates for Pharma KOLs","description":"Reports on Fair-Market Value Thought Leader compensation rates made by pharma to HCPs\/KOLs for various activities, specialties, KOL levels and countries.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/","og_locale":"en_US","og_type":"article","og_title":"KOL FMV - Thought Leader Compensation Rates for Pharma KOLs","og_description":"Reports on Fair-Market Value Thought Leader compensation rates made by pharma to HCPs\/KOLs for various activities, specialties, KOL levels and countries.","og_url":"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/","og_site_name":"Arx Research","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"CollectionPage","@id":"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/","url":"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/","name":"KOL FMV - Thought Leader Compensation Rates for Pharma KOLs","isPartOf":{"@id":"https:\/\/www.arxresearch.com\/#website"},"description":"Reports on Fair-Market Value Thought Leader compensation rates made by pharma to HCPs\/KOLs for various activities, specialties, KOL levels and countries.","breadcrumb":{"@id":"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/#breadcrumb"},"inLanguage":"en-US"},{"@type":"BreadcrumbList","@id":"https:\/\/www.arxresearch.com\/product-category\/thought-leader-compensation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arxresearch.com\/"},{"@type":"ListItem","position":2,"name":"KOL FMV Rates"}]},{"@type":"WebSite","@id":"https:\/\/www.arxresearch.com\/#website","url":"https:\/\/www.arxresearch.com\/","name":"Arx Research","description":"Medical Affairs Benchmarking","publisher":{"@id":"https:\/\/www.arxresearch.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arxresearch.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arxresearch.com\/#organization","name":"Arx Research","url":"https:\/\/www.arxresearch.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png","contentUrl":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png","width":217,"height":100,"caption":"Arx Research"},"image":{"@id":"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/arx-research"]}]}},"_links":{"self":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product_cat\/131"}],"collection":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"wp:post_type":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product?product_cat=131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}